Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours
Sign Up to like & getrecommendations! Published in 2022 at "Neuropathology and Applied Neurobiology"
DOI: 10.1111/nan.12813
Abstract: Rosette‐forming glioneuronal tumour (RGNT) is a rare central nervous system (CNS) World Health Organization (WHO) grade 1 brain neoplasm. According to the WHO 2021, essential diagnostic criteria are a ‘biphasic histomorphology with neurocytic and a… read more here.
Keywords: tumours midline; fgfr1 mutated; midline fgfr1; glioneuronal tumours ... See more keywords
DNA methylation‐based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification
Sign Up to like & getrecommendations! Published in 2023 at "Neuropathology and Applied Neurobiology"
DOI: 10.1111/nan.12894
Abstract: Glioneuronal tumours (GNTs) are poorly distinguished by their histology and lack robust diagnostic indicators. Previously, we showed that common GNTs comprise two molecularly distinct groups, correlating poorly with histology. To refine diagnosis, we constructed a… read more here.
Keywords: radiology; glioneuronal tumours; molecular stratification; methylation based ... See more keywords
Rare Neuronal, Glial and Glioneuronal Tumours in Adults
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15041120
Abstract: Simple Summary Glioneuronal and neuronal tumours are rare and mostly found in young adults and children, representing less than 5% of primary central nervous system (CNS) tumours. Accurate diagnosis is often difficult, requiring a significant… read more here.
Keywords: glioneuronal tumours; pathology; rare neuronal; tumours adults ... See more keywords